Alkoxylation of cannabidiol and other cannabinoids
US-2024383831-A1 · Nov 21, 2024 · US
US2016264730A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016264730-A1 |
| Application number | US-201415033303-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 24, 2014 |
| Priority date | Oct 31, 2013 |
| Publication date | Sep 15, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of producing a medical polyoxypropylene polymer and a polyoxypropylene/polyoxyethylene block copolymer including (A) adding to a polyoxypropylene polymer which is obtained by ring-opening polymerization of propylene oxide to a starting substance having an active hydrogen reacting with the propylene oxide and contains allyl ether as an impurity, a tertiary alkoxide of alkali metal in an excess amount based on a molar number of the active hydrogen of the starting substance and heat treating at 115° C. or less to isomerize the allyl ether to propenyl ether; and (B) adding a mineral acid to the product obtained in step (A) to adjust pH to 4 or less and treating at 70° C. or less to hydrolyze the propenyl ether. Also disclosed is a method of producing a medical polyoxypropylene/polyoxyethylene block copolymer which includes performing ring-opening polymerization of ethylene oxide to the polyoxypropylene polymer obtained above.
Opening claim text (preview).
1 . A production method of a medical polyoxypropylene polymer, comprising the following steps: (A) a step of adding to a polyoxypropylene polymer which is obtained by ring-opening polymerization of propylene oxide to a starting substance having an active hydrogen reacting with the propylene oxide and contains allyl ether as an impurity, a tertiary alkoxide of alkali metal in an excess amount based on a molar number of the active hydrogen of the starting substance and heat treating at 115° C. or less to isomerize the allyl ether to propenyl ether; and (B) a step of adding a mineral acid to the product obtained in the step (A) to adjust pH to 4 or less and treating at 70° C. or less to hydrolyze the propenyl ether. 2 . The method as claimed in claim 1 , performing after the step (B) described above, at least one of (C) a step of washing the polyoxypropylene polymer with water and (D) a step of treating the polyoxypropylene polymer with an inorganic adsorbent composed of an oxide containing at least one of aluminum and silicon. 3 . A production method of a medical polyoxypropylene/polyoxyethylene block copolymer comprising a step of performing ring-opening polymerization of ethylene oxide to the polyoxypropylene polymer obtained by the method as claimed in claim 1 . 4 . A production method of a medical polyoxypropylene/polyoxyethylene block copolymer comprising a step of performing ring-opening polymerization of ethylene oxide to the polyoxypropylene polymer obtained by the method as claimed in claim 2 .
containing oxygen {(cyclic ether compounds C08G65/26)} · CPC title
Post-polymerisation treatment, e.g. recovery, purification, drying · CPC title
the other compounds containing nitrogen · CPC title
for biomedical use · CPC title
characterised by the process or apparatus used · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.